GH receptor polymorfism: the effects on growth hormone substitution in patients with growth hormone deficiency

GH receptor polymorfism: the effects on growth hormone substitution in patients with growth hormone deficiency - GH receptor polymorfisms in adult GHD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30312

Enrollment

200

Registered

2007-01-26

Start date

2006-11-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

growth hormone deficiency

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Informed consent - All patients with growth hormone deficiency who have been treated with growth hormone substitution for at least one year

Exclusion criteria

Exclusion criteria: - Known pathogenic mutations in the growth hormone receptor that caused growth hormone deficiency.

Design outcomes

Primary

Measure	Time frame
1. The prevalence of the GH receptor polymorfisms. 2. The interactions of efficacy of GH substitution with GH receptor polymorfisms.	—

Secondary

Measure	Time frame
Not applicable.	—

Countries

Netherlands

Outcome results